Swiss Diversified Financial Stock News

Ypsomed Holding has seen its consensus analyst price target dip from CHF463.26 to CHF449.37, reflecting mixed analyst sentiment. Recent commentary highlights both bullish confidence in Ypsomed's leadership in the injectable market, as well as caution from others who question the sustainability of its growth following a company transformation. Stay tuned to discover how you can keep up with shifts in the evolving narrative for Ypsomed Holding stock. What Wall Street Has Been Saying Analyst...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Sika fair value estimate is CHF284 Current share price of...

What financial metrics can indicate to us that a company is maturing or even in decline? Businesses in decline often...

If you are standing at the crossroads of whether to buy, sell, or hold Julius Bär Gruppe, you are not alone. Investors have watched the stock make some strong moves in recent years, and there is a real question about whether the current price offers genuine value or a reason for caution. The stock’s journey has been anything but dull: while the past week and month have brought noticeable dips (down 5.7% and 8.7%, respectively), anyone who zooms out will see that the last twelve months...

VAT Group's (VTX:VACN) stock is up by a considerable 26% over the past month. Given the company's impressive...

With its stock down 3.9% over the past three months, it is easy to disregard INFICON Holding (VTX:IFCN). However, a...

While Rieter Holding AG ( VTX:RIEN ) might not have the largest market cap around , it received a lot of attention from...

To the annoyance of some shareholders, Rieter Holding AG ( VTX:RIEN ) shares are down a considerable 25% in the last...

Key Insights The projected fair value for Dätwyler Holding is CHF193 based on 2 Stage Free Cash Flow to Equity Current...

The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...

As European markets navigate a landscape of mixed economic signals and monetary policy decisions, the pan-European STOXX Europe 600 Index recently ended the week slightly lower. In this environment, dividend stocks may offer investors a potential source of steady income, especially as central banks maintain cautious stances on interest rates.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Galenica AG's ( VTX:GALE ) price-to-earnings (or "P/E") ratio of 21.9x might make it look like a sell right now...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

With a median price-to-earnings (or "P/E") ratio of close to 19x in Switzerland, you could be forgiven for feeling...

By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at...

Georg Fischer AG ( VTX:GF ), is not the largest company out there, but it maintained its current share price over the...

Despite posting some strong earnings, the market for Temenos AG's ( VTX:TEMN ) stock hasn't moved much. Our analysis...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

On September 1, 2025, Mobimo Holding AG acquired a 12,000 m² site in Meggen near Lake Lucerne, with plans to develop approximately 70 condominium units valued at CHF 120 million. The development taps into one of Central Switzerland’s most sought-after residential markets, further building on Mobimo’s track record in the region. We’ll explore how this significant pipeline expansion in an attractive location could shape Mobimo’s broader investment narrative. These 9 companies survived and...

Medacta Group SA recently reported strong half-year earnings, with sales reaching €344.14 million and net income rising to €60.04 million, while confirming 2025 guidance targeting 16% to 18% revenue growth in constant currency. Alongside these financial results, the company continued to expand its Personalized Sports Medicine Portfolio, launching the QuickStitch device at a major industry congress, highlighting ongoing investment in innovation and physician education. We'll examine how...

Tecan Group recently announced that Ralf Griebel, Head of the Partnering Business division and Management Board member since April 2020, has left the company, with Monica Manotas stepping in as interim leader to drive closer business collaboration. This leadership change in a core division highlights both succession planning and the company's ongoing efforts to maintain operational stability during executive transitions. We will assess how the shift in leadership for the Partnering Business...